Tag: ONO
Opivibo, the first cancer immunotherapy drug in China, approved by the Chinese National Drug Administration and Supervision Agency for indications of treatment non-small cell lung cancer with history
💊FDA & DRUG TODAY
💊Karyopharm’s Selinexor Receives Fast Track Designation from FDA for the Treatment of Patients with Penta-Refractory Multiple Myeloma
💊Ono Enters into New Collaboration Agreement with Merus N.V.